Azerbaijan Medical Device Certificate Validity: The 5-Year Rule and the Sell-Off Clause

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The national registration certificate for medical devices in Azerbaijan is valid for 5 years. This is confirmed by two mutually reinforcing sources: Article 6.11 of the Law on Medicinal Products, which states that the national registration certificate for medicinal products, pharmacologically active substances and medical devices is valid for 5 years, and paragraph 8.1 of Rule No. 345, which states that the certificate issued for medicinal products, pharmacologically active substances and medical devices is likewise valid for 5 years.

Expiry of the certificate does not mean that products already placed on the domestic market immediately lose their status: Article 6.12 of the Law provides that products placed into domestic circulation during the period of validity of the national registration may continue to be sold and used until their final use-by date expires, even after the national registration has lapsed. Paragraph 10.6 of the Rule further requires the state register to record the fact that the period of validity of the national registration has expired, together with the expiry date, and to make a corresponding entry in accordance with Article 6.12 of the Law.

2. Legal basis

  • Law of the Republic of Azerbaijan on Medicinal Products (Dərman vasitələri haqqında, Law of the Republic of Azerbaijan No. 208-IIIQ, adopted on December 22, 2006, entered into force on February 28, 2007, Collection of Legislation of the Republic of Azerbaijan, 2007, No. 2, Article 70), as amended by Law No. 979-VIQD of July 14, 2023 (which added Articles 1-1 and 9-1 as new provisions, Collection of Legislation, 2023, No. 8, Article 1127): Article 6.11 (certificate valid for 5 years), Article 6.12 (products placed into circulation during the validity period may continue to be sold and used until their final use-by date), Article 6.10 (state registration, re-registration and registration of changes are subject to the state duty under the Law on State Duty), Article 1.0.5-1 (definition of the state register of national registration), Article 16 (publication in the media).
  • Resolution of the Cabinet of Ministers of the Republic of Azerbaijan No. 345 of July 18, 2024, on the Rules for the National Registration of Medicinal Products, Pharmacologically Active Substances and Medical Devices, Their Inclusion in the State Register and the Maintenance of the State Register (entered into force on July 19, 2024; Xalq qəzeti, July 20, 2024, No. 151; Collection of Legislation, 2024, No. 7, Article 906; repealed Resolution No. 108 of July 13, 2007, with effect from July 20, 2024): paragraph 8.1 (certificate valid for 5 years), paragraph 7.8 (re-registration of devices to be filed at least 7 working days in advance), paragraph 7.9 (new certificate effective from the day following expiry of the previous certificate), paragraph 10.6 (register records expiry of the validity period and the expiry date).
  • Resolution of the Cabinet of Ministers of the Republic of Azerbaijan No. 140 of April 25, 2025 (amending the Rules annexed to Resolution No. 345, replacing the term registration certificate, qeydiyyat vəsiqəsi, with the term certificate, vəsiqə, throughout; Xalq qəzeti, April 30, 2025, No. 86; Collection of Legislation, 2025, No. 4, Book II, Article 426) (terminology amendment: registration certificate replaced by certificate).

3. Expert insights

Insight 1: The 5-year period is confirmed at both the level of the law and the level of the rule, which means it is not a technical parameter the Cabinet of Ministers can adjust at will. Article 6.11 states it once at the statutory level and paragraph 8.1 states it again at the rule level, creating a double lock. For companies, this means the 5-year period is a stable planning assumption on which lifecycle budgeting can be based; for the legislator, any adjustment would first require amending the law itself.

Insight 2: Article 6.12 is the sell-off clause for devices, and it matters enormously for inventory management. The provision allows products that were placed into domestic circulation during the period of validity of the national registration to continue to be sold and used until their final use-by date, even after registration has lapsed. For devices, the final use-by date typically refers to the shelf life or the service life of the product itself. Practical estimate: preserving evidence showing that the consignment entered domestic circulation during the validity period, such as the import permit, the customs declaration and warehouse receipts, is the precondition for relying on this provision.

Insight 3: Paragraph 10.6 makes expiry of the validity period a publicly visible status in the register. The register records the fact that the validity period has expired together with the expiry date, and makes a corresponding entry under Article 6.12. This means that an expired certificate is a status visible to the public: purchasers and competitors can both look it up. A delay in re-registration is therefore not merely an internal problem; it becomes externally observable.

Insight 4: The validity of the registration certificate is not synchronized with the QMS certificate or foreign registration documents. The registration certificate runs for 5 years, whereas the QMS certificate under paragraph 4.2.9 and the evidence of foreign registration under paragraph 4.2.2 are typically valid for 3 years or less. At re-registration under paragraph 7.8 these documents must still be valid, otherwise the dossier is incomplete. Plan the re-registration preparation period backwards from the shortest-lived supporting document, not from the 5-year certificate.

Insight 5: Resolution No. 140 renamed the registration certificate as the certificate, so pay attention to the version when citing. Resolution No. 140 of April 25, 2025 replaced the term qeydiyyat vəsiqəsi (registration certificate) with vəsiqə (certificate) throughout the Rules and removed the word REGISTRATION from the annex titles. The numbering of the provisions did not change and the validity period did not change, but the terminology did. Where external documents still refer to the registration certificate, it is advisable to add a note on the current terminology.

4. Practical recommendations

  1. Maintain a 5-year expiry ledger based on the certificate issue date, and plan the re-registration preparation period backwards from the shortest-lived supporting document, with dossier updates recommended to start 12 months in advance.
  2. When preparing for re-registration, renew the QMS certificate under paragraph 4.2.9 and the evidence of foreign registration under paragraph 4.2.2 at the same time, so that both are valid at the moment of filing.
  3. Preserve the evidence chain showing that the consignment entered domestic circulation during the validity period, including the import permit, customs declaration and warehouse receipts, for use in relying on Article 6.12.
  4. After the expiry is recorded in the register, proactively explain the sell-off arrangement under Article 6.12 to distributors so that continued sales are not mistaken for a violation.
  5. Use the current terminology, certificate (vəsiqə), in external documents, adding a note such as formerly called registration certificate where older texts are cited.
  6. Record three dates separately in the ledger: the certificate issue date, the expiry date and the date the re-registration application was filed, so that the 7-working-day window under paragraph 7.8 can be verified.

5. Verification checklist

  • □ The ledger records the certificate issue date and the 5-year expiry date.
  • □ The re-registration preparation period has been planned backwards from the shortest-lived supporting document (QMS certificate or foreign registration evidence).
  • □ An archiving mechanism for the evidence chain of consignments placed into domestic circulation during the validity period is in place.
  • □ The sell-off arrangement under Article 6.12 has been explained in writing to distributors.
  • □ External documents consistently use the current terminology, certificate (vəsiqə).
  • □ The ledger distinguishes the issue date, the expiry date and the re-registration filing date.

Regulatory information verified as of October 30, 2026.

This article was prepared and translated by GRZAN as part of the international medical device registration guide. For professional support with regulatory submissions in Azerbaijan and other jurisdictions, contact info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail